Viveve Medical, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
Viveve Medical, Inc. Earnings Date And Information
Viveve Medical, Inc. last posted its earnings results on Thursday, November 10th, 2022. The company reported $-0.59 earnings per share for the quarter, topping analysts' consensus estimates of $-0.66 by $0.07. The company had revenue of 1.68 M for the quarter and had revenue of 6.43 M for the year. Viveve Medical, Inc. has generated $-3 earnings per share over the last year ($-2.65 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Viveve Medical, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 3rd, 2024 based on prior year's report dates.
Viveve Medical, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/10/2022 | Q3 2022 | -$0.66 | -$0.50 | 0.16 | $1.68 M | $1.68 M |
| 08/11/2022 | Q2 2022 | -$0.67 | -$0.58 | 0.09 | $1.80 M | |
| 05/12/2022 | Q1 2022 | -$0.59 | -$0.58 | 0.01 | $1.64 M | |
| 03/17/2022 | Q4 2021 | -$0.63 | $1.71 M | |||
| 11/12/2021 | Q3 2021 | -$0.55 | $1.62 M | |||
| 08/12/2021 | Q2 2021 | -$0.65 | -$0.39 | 0.26 | $1.65 M | |
| 05/13/2021 | Q1 2021 | -$0.51 | -$0.67 | -0.16 | $1.45 M | |
| 03/18/2021 | Q4 2020 | -$2.19 | $1.95 M | |||
| 11/12/2020 | Q3 2020 | -$0.53 | -$2.07 | -1.54 | $1.52 M | |
| 08/13/2020 | Q2 2020 | -$0.59 | -$5.02 | -4.43 | $704,000 | |
| 05/14/2020 | Q1 2020 | -$12.60 | -$7.07 | 5.53 | $1.30 M | |
| 03/19/2020 | Q4 2019 | -$20.94 | $1.45 M | |||
| 11/07/2019 | Q3 2019 | -$16.00 | -$135.08 | -119.08 | $1.05 M | |
| 08/08/2019 | Q2 2019 | -$180.00 | -$209.28 | -29.28 | $1.05 M | |
| 05/09/2019 | Q1 2019 | -$300.00 | -$216.28 | 83.72 | $3.01 M | |
| 03/15/2019 | Q4 2018 | -$380.23 | $4.47 M | |||
| 11/08/2018 | Q3 2018 | -$330.00 | -$390.74 | -60.74 | $4.82 M | |
| 08/09/2018 | Q2 2018 | -$390.00 | -$367.86 | 22.14 | $5.53 M | |
| 05/10/2018 | Q1 2018 | -$400.00 | -$490.17 | -90.17 | $3.70 M | |
| 03/16/2018 | Q4 2017 | -$526.06 | $5.10 M |
Viveve Medical, Inc. Earnings: Frequently Asked Questions
-
When is Viveve Medical, Inc.'s earnings date?
Viveve Medical, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 3rd, 2024 based off last year's report dates.
-
Did Viveve Medical, Inc. beat their earnings estimates last quarter?
In the previous quarter, Viveve Medical, Inc. (:VIVE) reported $-0.59 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.66 by $0.07.
-
How can I listen to Viveve Medical, Inc.'s earnings conference call?
The conference call for Viveve Medical, Inc.'s latest earnings report can be listened to online.
-
How can I read Viveve Medical, Inc.'s conference call transcript?
The conference call transcript for Viveve Medical, Inc.'s latest earnings report can be read online.
-
How much revenue does Viveve Medical, Inc. generate each year?
Viveve Medical, Inc. (:VIVE) has a recorded annual revenue of $6.43 M.
-
How much profit does Viveve Medical, Inc. generate each year?
Viveve Medical, Inc. (:VIVE) has a recorded net income of $6.43 M. Viveve Medical, Inc. has generated $-2.65 earnings per share over the last four quarters.
-
What is Viveve Medical, Inc.'s price-to-earnings ratio?
Viveve Medical, Inc. (:VIVE) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.
